ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 109836 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 109836; 2) Community: the network communities that were significantly associated with the response to NSC 109836; 3) Molecule: the relationships between components within communities and NSC 109836; 4) MDR: the compounds that were significantly associated with the NSC 109836.

NSC Compound Enrichment Correlation
NSC 85700 Quinolinium, 2-[2-(8-hydroxy-5-quinolyl)vinyl]-1,6-methyl-, iodide (8CI) 0.0406225271888776 0.35809657
NSC 118218 2-Fluoro Ara A 0.0407060322613564 -0.036758652
NSC 123491 L-Cysteine, S-[tris(4-methylphenyl)methyl]- (9CI) 0.0407060322613564 0.13468739
NSC 149501 Bleomycinamide, N(1)-[3-[(4-aminobutyl)amino]propyl]-, sulfate (salt) 0.0407060322613564 0.11263628
NSC 172614 9H-Purin-2-amine, 9-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.0407060322613564 0.063026115
NSC 19441 FDA 0283 0.0407060322613564 0.37073775
NSC 343378 1H-Indene-1,3(2H)-dione, 2-[[(2-methylphenyl)imino]phenylmethyl]- 0.0407060322613564 -0.00015037496
NSC 48006 WLN: T6N CNJ DZ EF F- BT5OTJ EO1 0.0407060322613564 0.18486048
NSC 606869 Clofarabine 0.0407060322613564 0.12525704
NSC 645305 Null 0.0407060322613564 0.3453318
Total:62  Current:56    [First] [Prev] [Next] [Last]